XYL vs DOV vs OTIS
161 measures in 16 categories, one definition each, computed from filings and market data.
DOV57.6
Dover Corporation
Industrials · Industrial - Machinery
$195.80 +0.89%$26.4B mkt cap
Score DNA
OTIS54.1
Otis Worldwide Corporation
Industrials · Industrial - Machinery
$71.33 +1.34%$27.2B mkt cap
Score DNA
Price, rebased to 100 three years ago
XYL DOV OTIS · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| Insider open-market buys, 180d | 1 | 0 | 0 |
| Insider $ bought, 180d | $0.14M | — | — |
| Congress purchases, 180d | 4 | 1 | 6 |
| Last Congress purchase | 2026-09-25 | 2026-09-11 | 2026-08-27 |
| 13F net change in holders | −13 | +37 | −13 |
| ETFs adding shares, 30d | 1,013 | 979 | 1,011 |
| ETFs trimming, 30d | 896 | 835 | 926 |
| Net ETF funds, 30d | +117 | +144 | +85 |
Valuation
16 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| P/E (TTM) | 24.1x
30th
|
23.2x
24th
|
17.9x
13th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.67
21st
|
4.77
79th
|
2.52
66th
|
| Price / sales | 2.7x
56th
|
3.1x
64th
|
1.8x
31st
|
| Price / book | 2.3x
32nd
|
3.4x
47th
|
— |
| Price / tangible book | — | 44.4x
88th
|
— |
| Price / free cash flow | 25.3x
62nd
|
22.5x
52nd
|
15.9x
16th
|
| Price / operating cash flow | 18.7x
55th
|
18.9x
57th
|
14.5x
29th
|
| Enterprise value | $26.1B
79th
|
$27.9B
82nd
|
$35.2B
85th
|
| EV / sales | 2.9x
57th
|
3.3x
66th
|
2.4x
41st
|
| EV / EBITDA | 14.0x
34th
|
14.7x
39th
|
14.3x
36th
|
| EV / EBIT | 20.1x
41st
|
18.6x
30th
|
15.4x
15th
|
| EV / free cash flow | 27.2x
54th
|
23.8x
41st
|
20.6x
29th
|
| Earnings yield | 4.2%
74th
|
4.3%
79th
|
5.6%
89th
|
| FCF yield | 4.0%
43rd
|
4.4%
52nd
|
6.3%
85th
|
| Operating cash flow yield | 5.4%
48th
|
5.3%
46th
|
6.9%
72nd
|
| Graham number (per share) | $65.05
67th
|
$103.46
80th
|
— |
Profitability (TTM)
12 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| Gross margin | 39.2%
66th
|
39.6%
69th
|
30.2%
34th
|
| EBITDA margin | 20.4%
66th
|
22.5%
79th
|
16.5%
48th
|
| Operating margin | 14.5%
51st
|
16.9%
67th
|
15.4%
62nd
|
| EBIT margin | 14.2%
54th
|
17.8%
72nd
|
15.3%
62nd
|
| Net margin | 11.1%
64th
|
13.5%
77th
|
10.2%
59th
|
| NOPAT margin | 11.5%
57th
|
13.5%
67th
|
11.7%
59th
|
| FCF margin | 10.5%
43rd
|
13.9%
69th
|
11.5%
52nd
|
| Operating cash flow margin | 14.3%
52nd
|
16.5%
64th
|
12.5%
39th
|
| R&D / revenue | 2.5%
77th
|
0.5%
56th
|
1.0%
64th
|
| SG&A / revenue | 21.2%
59th
|
22.7%
70th
|
13.7%
25th
|
| Stock comp / revenue | 0.4%
27th
|
0.5%
33rd
|
0.2%
17th
|
| Effective tax rate | 20.7%
37th
|
20.1%
32nd
|
23.9%
75th
|
Returns on capital
11 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| ROE (on average equity) | 9.4%
36th
|
15.0%
61st
|
— |
| ROA | 5.8%
48th
|
8.5%
67th
|
14.0%
90th
|
| ROIC | 8.6%
38th
|
12.3%
59th
|
76.2%
98th
|
| ROCE | 8.9%
44th
|
13.4%
64th
|
78.1%
100th
|
| Return on tangible assets | 7.5%
43rd
|
11.2%
62nd
|
21.1%
97th
|
| Cash ROIC (OCF / invested capital) | 10.7%
40th
|
15.1%
60th
|
81.9%
97th
|
| Gross profitability (GP / assets) | 20.6%
34th
|
24.3%
48th
|
40.3%
95th
|
| ROIC, 3-yr average | 6.6%
28th
|
17.1%
86th
|
158.9%
100th
|
| ROIC, 5-yr average | 6.8%
32nd
|
19.6%
83rd
|
— |
| ROE, 5-yr average | 8.5%
31st
|
24.3%
87th
|
— |
| Incremental ROIC | 109.2%
81st
|
-153.8%
14th
|
173.1%
88th
|
Growth
17 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| Revenue growth (TTM YoY) | 4.5%
37th
|
7.6%
53rd
|
5.2%
42nd
|
| Revenue growth (QoQ) | 9.9%
54th
|
6.6%
36th
|
8.2%
43rd
|
| Revenue CAGR, 3 yr | 14.6%
92nd
|
-0.2%
17th
|
2.5%
37th
|
| Revenue CAGR, 5 yr | 11.9%
82nd
|
2.5%
16th
|
1.5%
7th
|
| Gross profit CAGR, 3 yr | 16.0%
90th
|
3.1%
29th
|
3.6%
36th
|
| Operating income CAGR, 3 yr | 29.0%
92nd
|
1.4%
24th
|
2.2%
27th
|
| Net income growth (TTM YoY) | 7.7%
65th
|
-50.5%
10th
|
0.2%
53rd
|
| Net income CAGR, 3 yr | 42.1%
92nd
|
3.6%
51st
|
4.5%
53rd
|
| EPS growth (TTM YoY) | 11.0%
67th
|
-49.6%
12th
|
3.0%
53rd
|
| EPS CAGR, 3 yr | 35.9%
90th
|
4.9%
53rd
|
7.1%
55th
|
| EPS CAGR, 5 yr | 15.0%
72nd
|
6.7%
46th
|
8.0%
54th
|
| FCF growth (TTM YoY) | 9.0%
50th
|
110.8%
94th
|
27.0%
71st
|
| FCF CAGR, 3 yr | 39.1%
85th
|
12.2%
43rd
|
9.4%
32nd
|
| Operating cash flow CAGR, 3 yr | 31.4%
83rd
|
10.2%
45th
|
9.5%
38th
|
| Book value CAGR, 3 yr | -2.7%
5th
|
19.7%
88th
|
— |
| Dividend CAGR, 3 yr | -1.8%
12th
|
1.0%
36th
|
4.0%
78th
|
| Sustainable growth rate | 5.7%
26th
|
11.3%
56th
|
— |
Margin history & stability
7 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| Gross margin, 3-yr average | 38.0%
58th
|
38.8%
65th
|
30.2%
35th
|
| Operating margin, 3-yr average | 12.4%
45th
|
16.4%
68th
|
15.1%
60th
|
| Net margin, 3-yr average | 10.3%
53rd
|
20.6%
98th
|
10.4%
55th
|
| FCF margin, 3-yr average | 10.4%
47th
|
11.6%
57th
|
9.9%
42nd
|
| Revenue stability (0-1) | 0.90
70th
|
0.32
17th
|
0.68
32nd
|
| Earnings stability (0-1) | 0.85
90th
|
0.29
37th
|
0.94
97th
|
| Margin stability (0-1) | 0.98
83rd
|
0.96
73rd
|
0.98
92nd
|
Liquidity (latest quarter)
7 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| Cash & short-term investments | $1.3B
87th
|
$1.8B
93rd
|
$813.0M
80th
|
| Net cash (− = net debt) | −$1.8B
28th
|
−$1.5B
39th
|
−$8.0B
5th
|
| Working capital | $1.7B
92nd
|
$2.4B
97th
|
−$1.4B
2nd
|
| Current ratio | 1.61
31st
|
1.98
41st
|
0.83
0th
|
| Quick ratio | 1.24
56th
|
1.41
66th
|
0.75
11th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.47
64th
|
0.70
79th
|
0.10
11th
|
| Defensive interval (days) | 509 days
59th
|
625 days
70th
|
929 days
90th
|
Leverage & solvency (latest quarter)
13 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| Total debt | $3.1B
77th
|
$3.3B
79th
|
$8.8B
93rd
|
| Debt / equity | 0.29
22nd
|
0.42
33rd
|
— |
| Net debt / equity | 0.17
28th
|
0.20
30th
|
— |
| Debt / assets | 17.6%
23rd
|
23.8%
38th
|
79.3%
100th
|
| Debt / capital | 22.7%
22nd
|
29.7%
33rd
|
— |
| Debt / EBITDA | 1.64
34th
|
1.72
39th
|
3.60
75th
|
| Net debt / EBITDA | 0.96
36th
|
0.79
30th
|
3.27
84th
|
| Interest coverage (EBIT / interest) | 56.3x
96th
|
13.2x
71st
|
10.9x
61st
|
| Cash interest coverage | 56.6x
96th
|
12.2x
73rd
|
8.9x
57th
|
| Debt payback (years of OCF) | 2.3 yrs
45th
|
2.3 yrs
43rd
|
4.7 yrs
72nd
|
| Liabilities / assets | 39.9%
11th
|
43.7%
23rd
|
149.8%
100th
|
| IS credit model rating | AA- | AA- | B- |
| Implied credit spread (bps) | 100
21st
|
100
21st
|
900
98th
|
Efficiency
11 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| Asset turnover | 0.53
20th
|
0.63
38th
|
1.38
97th
|
| Fixed asset turnover | 7.82
80th
|
7.56
74th
|
11.17
93rd
|
| Inventory turnover | 5.3
89th
|
3.7
56th
|
16.2
100th
|
| Receivables turnover | 4.9
21st
|
5.6
41st
|
3.5
3rd
|
| Days sales outstanding | 74 days
79th
|
65 days
59th
|
103 days
97th
|
| Days inventory outstanding | 69 days
11th
|
98 days
44th
|
23 days
0th
|
| Days payables outstanding | 68 days
80th
|
65 days
75th
|
67 days
77th
|
| Cash conversion cycle (days) | 75 days
11th
|
97 days
33rd
|
59 days
5th
|
| Capex / revenue | 3.7%
80th
|
2.6%
60th
|
1.1%
2nd
|
| Capex / depreciation | 0.60
45th
|
0.56
38th
|
0.92
72nd
|
| Operating expense ratio | 24.5%
70th
|
22.3%
59th
|
14.5%
18th
|
Cash flow & earnings quality
7 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| Operating cash flow / net income | 1.29
33rd
|
1.23
27th
|
1.23
29th
|
| FCF / net income | 0.95
24th
|
1.03
31st
|
1.13
38th
|
| FCF / operating cash flow | 73.8%
26th
|
84.3%
54th
|
91.5%
88th
|
| Capex / operating cash flow | 26.2%
74th
|
15.7%
46th
|
8.5%
12th
|
| Accruals ratio | -1.7%
72nd
|
-1.9%
70th
|
-3.3%
51st
|
| Sloan accruals ratio | -5.6%
15th
|
0.0%
64th
|
-6.5%
10th
|
| Earnings quality score (0-1) | 1.00
25th
|
1.00
25th
|
1.00
25th
|
Scores & forensic checks
15 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| IS score | 60
61st
|
58
48th
|
54
43rd
|
| IS profitability | 45
49th
|
55
66th
|
41
44th
|
| IS growth | 48
53rd
|
28
15th
|
54
67th
|
| IS value | 50
61st
|
49
57th
|
50
62nd
|
| IS momentum | 77
62nd
|
59
20th
|
73
50th
|
| IS risk (safety) | 90
36th
|
100
48th
|
65
23rd
|
| IS quality | 77
70th
|
78
79th
|
60
21st
|
| IS balance sheet | 72
66th
|
77
79th
|
40
8th
|
| IS earnings quality | 76
70th
|
77
80th
|
68
23rd
|
| IS cash flow | 58
39th
|
69
74th
|
64
61st
|
| Piotroski F-score (0-9) | 7
61st
|
7
61st
|
5
20th
|
| Altman Z-score | 3.6
38th
|
5.7
70th
|
2.8
28th
|
| Beneish M-score | −2.56
43rd
|
−2.56
45th
|
−2.52
52nd
|
| Ohlson O-score | −9.10
11th
|
−8.84
21st
|
−3.68
100th
|
| IS credit score | 84
70th
|
85
79th
|
20
2nd
|
Size (TTM)
8 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| Market cap | $24.3B
79th
|
$26.4B
80th
|
$27.2B
82nd
|
| Revenue | $9.1B
85th
|
$8.4B
82nd
|
$14.9B
87th
|
| EBITDA | $1.9B
82nd
|
$1.9B
84th
|
$2.5B
87th
|
| Net income | $1.0B
82nd
|
$1.1B
84th
|
$1.5B
89th
|
| Free cash flow | $960.0M
80th
|
$1.2B
82nd
|
$1.7B
87th
|
| Total assets | $17.3B
87th
|
$13.7B
82nd
|
$11.2B
80th
|
| Shareholders' equity | $10.4B
90th
|
$7.7B
85th
|
−$5.7B
0th
|
| Employees | 22,000
80th
|
24,000
82nd
|
72,000
98th
|
Price performance
9 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| 1 day | +0.7% | +0.9% | +1.3% |
| 1 week | +1.3% | +3.7% | +8.2% |
| 1 month | −3.3% | +3.5% | +3.8% |
| 3 months | −13.7% | −6.6% | −2.9% |
| 6 months | −14.1% | −10.6% | −12.4% |
| Year to date | −23.8% | +0.3% | −18.9% |
| 1 year | −28.4% | +20.7% | −21.6% |
| 3 years, cumulative | +15.7% | +41.4% | −8.6% |
| 5 years, cumulative | −9.8% | +31.0% | −8.7% |
Technicals
4 measures| Measure | XYL | DOV | OTIS |
|---|---|---|---|
| RSI 14 | 47.3 | 59.5 | 65.0 |
| From 52-week high | −32.4% | −17.4% | −24.6% |
| From 52-week low | +5.6% | +20.2% | +12.2% |
| Beta | 0.99 | 1.13 | 0.86 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17